Brussels, 22/11/2011 (Agence Europe) - The European Investment Bank (EIB) has pledged to take part in the funding of pharmaceutical research programmes, especially in the field of biotherapy, with Laboratoires Pierre Fabre. On Friday 18 November, concrete substance was given to the commitment with the signing of a funding contract amounting to €100 million between Laboratoires Pierre Fabre and the EIB.
The bank loan will allow funding for R&D projects currently conducted by Laboratoires...